Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aprepitant for paediatric chemotherapy-induced nausea and vomiting.
Slimano F, Rigaud C, Annereau M, Gaspar N, Lemare F. Slimano F, et al. Among authors: annereau m. Lancet Oncol. 2015 Jun;16(6):e259. doi: 10.1016/S1470-2045(15)70205-6. Epub 2015 May 27. Lancet Oncol. 2015. PMID: 26065607 No abstract available.
[Consortium for detection and management of lung damage induced by bleomycin].
Biya J, Stoclin A, Dury S, Le Pavec J, Mir O, Lazarovici J, Fermé C, Annereau M, Ekpe K, Massard C, Michot JM. Biya J, et al. Among authors: annereau m. Bull Cancer. 2016 Jul-Aug;103(7-8):651-61. doi: 10.1016/j.bulcan.2016.04.005. Epub 2016 May 27. Bull Cancer. 2016. PMID: 27241272 Review. French.
ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.
Kossmann CM, Annereau M, Thomas-Schoemann A, Nicco-Overney C, Chéreau C, Batteux F, Alexandre J, Lemare F. Kossmann CM, et al. Among authors: annereau m. Tumour Biol. 2017 Jul;39(7):1010428317716077. doi: 10.1177/1010428317716077. Tumour Biol. 2017. PMID: 28675123 Free article.
Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC.
Roy P, Canet-Jourdan C, Annereau M, Zajac O, Gelli M, Broutin S, Mercier L, Paci A, Lemare F, Ducreux M, Elias D, Malka D, Boige V, Goéré D, Jaulin F. Roy P, et al. Among authors: annereau m. Int J Pharm. 2017 Oct 5;531(1):143-152. doi: 10.1016/j.ijpharm.2017.07.084. Epub 2017 Aug 11. Int J Pharm. 2017. PMID: 28803938
High incidence of cetuximab-related infusion reactions in head and neck patients.
Palomar Coloma V, Bravo P, Lezghed N, Mayache-Badis L, Herrera Gómez RG, Iacob M, Nicouleau L, Desmaris R, Tao Y, Leibu C, Matias M, Lemare F, Even C, Annereau M, Ferté C. Palomar Coloma V, et al. Among authors: annereau m. ESMO Open. 2018 Jul 23;3(5):e000346. doi: 10.1136/esmoopen-2018-000346. eCollection 2018. ESMO Open. 2018. PMID: 30094066 Free PMC article.
High-dose cyclophosphamide for hard-to-treat patients with relapsed or refractory B-cell non-Hodgkin's lymphoma, a phase II result.
Michot JM, Annereau M, Danu A, Legoupil C, Bertin L, Chahine C, Achab N, Antosikova A, Cerutti A, Rossignol J, Ghez D, Willekens C, Dartigues P, Lazarovici J, Lemare F, Ribrag V. Michot JM, et al. Among authors: annereau m. Eur J Haematol. 2020 Apr;104(4):281-290. doi: 10.1111/ejh.13369. Epub 2020 Jan 28. Eur J Haematol. 2020. PMID: 31838764 Clinical Trial.
5-Azacitidine in patients with IDH1/2-mutant recurrent glioma.
Federici L, Capelle L, Annereau M, Bielle F, Willekens C, Dehais C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY, Idbaih A, Lemare F, de Botton S, Sanson M, Touat M. Federici L, et al. Among authors: annereau m. Neuro Oncol. 2020 Aug 17;22(8):1226-1228. doi: 10.1093/neuonc/noaa074. Neuro Oncol. 2020. PMID: 32215616 Free PMC article. No abstract available.
30 results